Healthcare & Wellness
·
4 min read
AstraZeneca Signs $1.5 Billion AI Drug Discovery Deal with Insitro for Liver and Heart Targets
AstraZeneca signed a deal worth up to $1.5 billion with AI drug discovery company insitro to identify novel drug targets in liver and heart disease using insitro's machine learning platform.
2h ago